Annovis Bio Stock Buy Hold or Sell Recommendation
| ANVS Stock | USD 6.71 0.17 2.60% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Annovis Bio is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Annovis Bio given historical horizon and risk tolerance towards Annovis Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for Annovis Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Annovis Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide. Note, we conduct extensive research on individual companies such as Annovis and provide practical buy, sell, or hold advice based on investors' constraints. Annovis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Annovis |
Execute Annovis Bio Buy or Sell Advice
The Annovis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Annovis Bio. Macroaxis does not own or have any residual interests in Annovis Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Annovis Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Annovis Bio Trading Alerts and Improvement Suggestions
| Annovis Bio generated a negative expected return over the last 90 days | |
| Annovis Bio has high historical volatility and very poor performance | |
| Annovis Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (56.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Annovis Bio currently holds about 35.97 M in cash with (39.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.41. | |
| Annovis Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20 Key Pharma Companies Actively Working in the Therapeutics Segment DelveInsight DelveInsight |
Annovis Bio Returns Distribution Density
The distribution of Annovis Bio's historical returns is an attempt to chart the uncertainty of Annovis Bio's future price movements. The chart of the probability distribution of Annovis Bio daily returns describes the distribution of returns around its average expected value. We use Annovis Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Annovis Bio returns is essential to provide solid investment advice for Annovis Bio.
| Mean Return | -0.32 | Value At Risk | -5.94 | Potential Upside | 6.62 | Standard Deviation | 4.23 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Annovis Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Annovis Stock Institutional Investors
The Annovis Bio's institutional investors refer to entities that pool money to purchase Annovis Bio's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Bridgeway Capital Management, Llc | 2024-09-30 | 22.1 K | Northern Trust Corp | 2024-09-30 | 21.9 K | Spears Abacus Advisors Llc | 2024-09-30 | 20 K | Bank Of New York Mellon Corp | 2024-06-30 | 19.1 K | Greenwich Wealth Management Llc | 2024-09-30 | 16.5 K | Ubs Group Ag | 2024-06-30 | 13 K | Lokken Investment Group Llc | 2024-06-30 | 12.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 11 K | Jane Street Group Llc | 2024-06-30 | 10.1 K | Vanguard Group Inc | 2024-09-30 | 380.3 K | Citadel Advisors Llc | 2024-09-30 | 102.7 K |
Annovis Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Annovis Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Annovis Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Annovis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.43 | |
β | Beta against Dow Jones | 0.76 | |
σ | Overall volatility | 4.31 | |
Ir | Information ratio | -0.11 |
Annovis Bio Volatility Alert
Annovis Bio exhibits very low volatility with skewness of 0.98 and kurtosis of 1.34. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Annovis Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Annovis Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Annovis Bio Fundamentals Vs Peers
Comparing Annovis Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Annovis Bio's direct or indirect competition across all of the common fundamentals between Annovis Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Annovis Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Annovis Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Annovis Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Annovis Bio to competition |
| Fundamentals | Annovis Bio | Peer Average |
| Return On Equity | -5.97 | -0.31 |
| Return On Asset | -1.55 | -0.14 |
| Current Valuation | 77.6 M | 16.62 B |
| Shares Outstanding | 13.8 M | 571.82 M |
| Shares Owned By Insiders | 20.40 % | 10.09 % |
| Shares Owned By Institutions | 8.83 % | 39.21 % |
| Number Of Shares Shorted | 1.39 M | 4.71 M |
| Price To Earning | (0.43) X | 28.72 X |
| Price To Book | 12.77 X | 9.51 X |
| EBITDA | (45.04 M) | 3.9 B |
| Net Income | (56.2 M) | 570.98 M |
| Cash And Equivalents | 35.97 M | 2.7 B |
| Cash Per Share | 4.41 X | 5.01 X |
| Total Debt | 17.96 M | 5.32 B |
| Debt To Equity | (0.31) % | 48.70 % |
| Current Ratio | 28.11 X | 2.16 X |
| Book Value Per Share | 0.53 X | 1.93 K |
| Cash Flow From Operations | (39.97 M) | 971.22 M |
| Short Ratio | 4.02 X | 4.00 X |
| Earnings Per Share | (4.22) X | 3.12 X |
| Target Price | 34.8 | |
| Number Of Employees | 6 | 18.84 K |
| Beta | 1.7 | -0.15 |
| Market Capitalization | 92.58 M | 19.03 B |
| Total Asset | 10.21 M | 29.47 B |
| Retained Earnings | (110.26 M) | 9.33 B |
| Working Capital | 5.93 M | 1.48 B |
| Current Asset | 986 K | 9.34 B |
| Current Liabilities | 216 K | 7.9 B |
| Net Asset | 10.21 M |
Note: Disposition of 222222 shares by Michael Hoffman of Annovis Bio subject to Rule 16b-3 [view details]
Annovis Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Annovis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Annovis Bio Buy or Sell Advice
When is the right time to buy or sell Annovis Bio? Buying financial instruments such as Annovis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Annovis Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run JPY Crypto Assets Thematic Idea Now
JPY Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Japanese Yen. The JPY Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize JPY Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Annovis Stock Analysis
When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.